medigraphic.com
Colegio de Medicina Interna de México.

2015, Número 2

<< Anterior Siguiente >>

Med Int Mex 2015; 31 (2)


Hemofilia adquirida. Una causa rara de hemorragia obstétrica

Benardete-Harari DN, Sánchez-Cárdenas AG, Meraz-Ávila D, Nellen-Hummel H, Halabe-Cherem J

Idioma: Español
Referencias bibliográficas: 49
Paginas: 174-180
Archivo PDF: 422.95 Kb.


RESUMEN

La hemofilia adquirida es una enfermedad autoinmunitaria rara; cerca de 7 a 14% de todos los casos ocurre en el periodo posparto en el que se desarrolla un autoanticuerpo dirigido contra el factor VIII, que se manifiesta con hemorragia clínicamente significativa. Se debe sospechar si hay un recuento plaquetario normal, tiempo de protrombina normal con prolongación del tiempo de tromboplastina parcial activado que no se corrige con plasma. El tratamiento de la hemofilia posparto tiene como objetivo disminuir la hemorragia para disminuir la morbilidad y mortalidad.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Massimo F, Giovanni T, et al. Acquired factor VIII inhibitors in oncohematology: A systematic review. Crit Rev Oncol Hematol 2008;66:194-199.

  2. Delgado J, Yimenez-Yuste V, Hernandez-Navarro F, Villar A. Acquired haemophilia: review and meta-analysis focused on therapy and prognostic factors. Br J Haematol 2003;121:21-35.

  3. Boggio LN, Green D. Acquired hemophilia. Rev Clin Exp Hematol 2001;5:389-404.

  4. Pruthi RK, Nichols WL. Autoimmune factor VIII inhibitors. Curr Opin Hematol 1999;6:314-322.

  5. Mytopher K, Dudebout J, Card R, Gilliland B. Teaching Case Report: Acquired hemophilia A presenting post partum. CMAJ 2007;177:339-340.

  6. Sedigheh Borna, Sedigheh Hantoushzadeh. Acquired hemophilia as a cause of primary postpartum hemorrhage. Arch Iranian Med 2007;10:107-110.

  7. Mulliez S, Vantilborgh A, Devreese K. Acquired hemophilia: a case report and review of the literature. Int J Lab Hem 2014;36:398-407.

  8. Yee TT, Pasi KJ, Lilley PA, Lee CA. Factor VIII inhibitors in haemophiliacs: a single-centre experience over 34 years, 1964-1997. Br J Haematol 1999;104:909-914.

  9. Baudo F, de Cataldo F. Acquired factor VIII inhibitors in pregnancy: data from the Italian Haemophilia Register relevant to clinical practice. BJOG 2003;110:311-314.

  10. Meiklejohn DJ, Watson HG. Acquired haemophilia in association with organ-specific autoimmune disease. Haemophilia 2001;7:523-525.

  11. Sallah S, Nguien NP, Abdallah JM, Hanrahan LR. Acquired hemophilia in patients with hematologic malignancies. Arch Pathol Lab Med 2000;124:730-734.

  12. Hauser I, Lechner K. Solid tumors and factor VIII antibodies. Thromb Haemost 1999;82:1005-1007.

  13. Sallah S, Wan JY. Inhibitors against factor VIII in patients with cancer. Cancer 2001;91:1067-1074.

  14. Franchini M. Postpartum acquired factor VIII inhibitors. Am J Hematol 2006;81:768-773.

  15. Tengborn L, Baudo F, Huth-Kühne A, Knoebl P, et al. Pregnancy-associated acquired haemophilia A: results from the European Acquired Haemophilia (EACH2) registry. BJOG 2012;119:1529-1537.

  16. Weston Smith SG, Revell P, Lawrie AS, Holland LJ, Savidge GF. The rapid development of an IgM inhibitor of porcine factor VIII in a patient with acquired haemophilia. Br J Haematol 1990;75:434-436.

  17. Carmona E, Aznar JA, Jorquera JI, Villanueva MJ, Sanchez- Cuenca JM. Detection of two different anti-factor VIII/von Willebrand factor antibodies of the IgA class in a hemophilic patient with a polyclonal factor VIII inhibitor of the IgG class. Thromb Res 1991;63:73-84.

  18. Reding MT. Immunological aspects of inhibitor development. Haemophilia 2006;12:30-36.

  19. Reding MT, Lei S, Lei H, Green D, et al. Distribution of Th1- and Th2-induced anti-factor VIII IgG subclasses in congenital and acquired hemophilia patients. Thromb Haemost 2002;88:568-575.

  20. Reding MT, Okita DK, Diethelm-Okita BM, Anderson TA, Conti-Fine BM. Human CD4+T-cell epitope repertoire on the C2 domain of coagulation factor VIII. J Thromb Haemost 2003;1:1777-1784.

  21. Oldenburg J, Zeitler H, Pavlova A. Genetic markers in acquired haemophilia. Haemophilia 2010;16:41-45.

  22. Pavlova A, Zeitler H, Scharrer I, Brackmann HH, Oldenburg J. HLA genotype in patients with acquired haemophilia A. Haemophilia 2010;16:107-112.

  23. Karlsson H, Pérez C. Postpartum haemorrhage. An Sist Sanit Navar 2009;32:159-167.

  24. Almagro D. La hemostasia en el embarazo. Rev Cub Hematol Inmunol Hemoter 2000;16:90-98.

  25. Boudo F. Acquired factor VIII inhibitors in pregnancy: data from the Italian Hemophilia Register relevant to clinical practice. Int J Obstet Gynecol 2003;110:311-314.

  26. Howland EJ, Palmer J, Lumley M, Keay SD. Acquired factor VIII inhibitors as a cause of primary postpartum hemorrhage. Eur J Obstet Gynecol 2002;103:97-98.

  27. Astermark J, Donfield SM, Di Michele DM, et al. A randomized comparison of bypassing agents in hemophilia com plicated by an inhibitor: the FEIBA novoseven comparative (FENOC) study. Blood 2007;109:546-551.

  28. Buseri F, Jeremiah Z, Kalio F. Influence and gestation period on some coagulation parameters among Nigerian antenatal women. Res J Med Science 2008;2:275-281.

  29. Djelmis J, Ivanisevic M, Kurjak A, Mayer D. Hemostatic problems before, during and after delivery. J Perinat Med 2001;29:241-246.

  30. Norris L. Blood coagulation. Best Pract Res Clin Obstet Gynaecol 2003;17:369-383.

  31. Uchikova E, Ledjev I. Changes in haemostasis during normal pregnancy. Eur J Obstet Gynecol Reprod Biol 2005;119:185- 188.

  32. Conte G, Figueroa G, Aravena P, Gonzáles N, Araos D, Cuneo M. Hemofilia adquirida tratada con anti-CD20, un anticuerpo antilinfocito B. Rev Méd Chil 2011;139:357-361.

  33. Knoebl P, Marco P, Baudo F, Collins P, et al. Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2). J Thromb Haemost 2012;10:622-631.

  34. Solymoss S. Postpartum acquired factor VIII inhibitors: results of a survey. Am J Hematol 1998;59:1-4.

  35. Ma AD, Carrizosa D. Acquired factor VIII inhibitors: pathophysiology and treatment. Hematol Am Soc Hematol Educ Program 2006;432-437.

  36. Huth-Kuhne A, Baudo F, Collins P, Ingerslev J, et al. International recommendations on the diagnosis and treatment of patients with acquired hemophilia A. Haematologica 2009;94:566-575.

  37. Collins P, Baudo F, Huth-Kuhne A, Ingerslev J, et al. Consensus recommendations for the diagnosis and treatment of acquired hemophilia A. BMC Res Notes 2010;3:161. 38.. Lossing TS, Kasper CK, Feinstein DI. Detection of factor VIII inhibitors with the partial thromboplastin time. Blood 1977;49:793-797.

  38. Pruthi RK, Nichols WL. Autoimmune factor VIII inhibitors. Curr Opin Hematol 1999;6:314-322.

  39. Ma AD, Carrizosa D. Acquired factor VIII inhibitors: pathophysiology and treatment. Hematology Am Soc Hematol Educ Program 2006;1:432-437.

  40. Hauser I, Schneider B, Lechner K. Postpartum factor VIII inhibitors. A review of the literature with special reference to the value of steroid and immunosuppressive treatment. Thromb Haemost 1995;73:1-5.

  41. Del Valle Rubido C y col. Hemofilia A adquirida posparto: guía de diagnóstico y tratamiento a raíz de un caso clínico. Prog Obstet Ginecol 2014.

  42. Cabezas-Poblet M, Pérez-García R, Argíz-Muñiz A, Quintero- Méndez Y. Hemofilia adquirida en el postparto. Presentación de un caso. Rev Finlay 2012;2.

  43. Michiels JJ. Acquired hemophilia A in womenpostpartum: clinical manifestations, diagnosis, and treatment. Clin Appl Thromb Hemost 2000;6:82-86.

  44. García J, Vela J, García A, et al. Respuesta a largo plazo con rituximab en una paciente con hemofilia adquirida. Rev Invest Clin 2011;63:210-212.

  45. García-Chavez J, Majluf-Cruz A, Montiel-Cervantes L, García- Ruiz Esparza M, Vela-Ojeda J. Rituximab therapy for chronic and refractory immune thrombocytopenic purpura: a long- term follow-up analysis. Ann Hematol 2007;86:871- 877.

  46. Collins PW, Hirsch S, Baglin TP, Dolan G, et al. Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors’ Organisation. Blood 2007;109:1870-1877.

  47. Tay L, Duncan E, Singhal D, Al-Qunfoidi R, et al. Twelve years of experience of acquired hemophilia A: trials and tribulations in South Australia. Semin Thromb Hemost 2009;35:769-777.

  48. Solymoss S. Postpartum acquired factor VIII inhibitors: results of a survey. Am J Hematol 1998;59:1-4.

  49. Hauser I, Schneider B, Lechner K. Post-partum factor VIII inhibitors. A review of the literature with special reference to the value of steroid and immunosuppressive treatment. Thromb Haemost 1995;73:1-5.




2020     |     www.medigraphic.com